Uniting preclinical, translational and discovery scientists. Tweeting about innovations in applications of models in R&D. Discover the upcoming PREDiCT events.
Visit us @PREDiCT_Models Summit in Boston this week and learn how StemoniX products are being used by some of our collaborators! We hope to see you there. Contact us at [email protected] to set up a meeting!
Really interesting work using chip-based 3D models. Given the lack of predictive #models, and only 2 approved symptomatic treatments for idiopathic #pulmonaryfibrosis, clearly, this holds a lot of promise in advancing future therapies
https://t.co/jwAttVCqGf https://t.co/3LoVUBZlyO
Love seeing all the great research outcomes from organ-on-a-chip projects: here is a recent publication from the University of Buffalo. Dr. Zhao and team simulate pulmonary fibrosis with their lung-on-a-chip system for drug testing. https://t.co/pHWyGq8qv7
Fascinating work from @wakeforest. Researchers developed a #3D#organoid model recapitulating the BBB and mimicking normal human anatomy with huge implications for #stroke research
https://t.co/S7AZSs0Zrg
A fascinating presentation from @dangville on the development a new #3Dmodel done in collaboration with @HemoShear for the study of #pancreatic#cancer and #NSCLC. Great to see the novel incorporation of tumor hemodynamics and biological transport #3DOncology18
"A model is a lie that helps you see the truth - the goal with 3D is to minimise that lie"
Asellus CEO Brett Hall & @MitraBiotech's Mark Paris explore how 3D Models are revealing molecular and phenotypic insights over 2D models.
#3DOncology18
Its been a fascinating morning at #3doncology concluded by the @scrippsresearch Tim Spicer on the use of #3D#spheroids models in discovery. Was amazing to not only see the progress of these platforms in automated ultra HTP formats but thier power over 2D models
Great presentation from @GSK's Jason Ekert exploring some of the scaling and automation challenges for #3D#tumor#spheroids. Was fascinating to see how they've informed their emerging bispecific compounds.
Researchers at Houston Methodist have published data on their "4D" model to show the growth of primary tumours, the formation of CTCs and formation of metastatic lesions
https://t.co/DVGJ2zvIFG
Happy 5th Birthday to Sanger's cell makers! Their expertise in #stemcells, #organoids and #CRISPR powers our large-scale projects into health and disease https://t.co/rLBMVrrapk
"The ML models that are developed will then help guide subsequent experiments, providing a tight, closed loop integration of in silico and in vitro methods (an insitro paradigm).” @JohnCendpts - https://t.co/SdAgfFqM6r
Scientists from @wyssinstitute, @JanssenUS & @emulatebio publish results showing the translational potential #organonchip to better predict thrombotic side effects of drug candidates.
https://t.co/gMGv4EuKWz
@Roche researchers using @MIMETAS_3D microfluidic #3Dculture tech have begun to elucidate the mechanistic effects underlying diarrhea induced by anti-HER2/3 #combinationtherapy
https://t.co/cjrRFpe1LM